Back to Search
Start Over
Continued efficacy of neratinib in patients with HER2-positive (HER2+) early-stage breast cancer: final overall survival (OS) analysis from the randomized phase 3 ExteNET trial
- Source :
- Breast, Vol 56, Iss , Pp S19- (2021)
- Publication Year :
- 2021
- Publisher :
- Elsevier, 2021.
- Subjects :
- Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Subjects
Details
- Language :
- English
- ISSN :
- 15323080 and 09609776
- Volume :
- 56
- Issue :
- S19-
- Database :
- Directory of Open Access Journals
- Journal :
- Breast
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.888041cad74349f8bde5798f3db940d7
- Document Type :
- article
- Full Text :
- https://doi.org/10.1016/S0960-9776(21)00093-X